Lv51
1470 积分 2022-02-10 加入
New payloads drive next-gen antibody–drug conjugates
21天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
21天前
已完结
The Antigenicity of the Tumor Cell — Context Matters
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Roads and detours for CAR T cell therapy in autoimmune diseases
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
2个月前
已完结
Clinical development of cancer vaccines
2个月前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics
2个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
